Partial loss of Glo1 resulted in obesity, hyperglycemia, dyslipidemia, and alterations in lipid metabolism in metabolic tissues in an age- and sex-dependent manner. This evidence concerns the gene GLO1 and obesity due to melanocortin 4 receptor deficiency.